Post Categories
When NSAAs Enter the Mix, Protein Therapeutics May Thrive
November 15, 2021
Protein therapeutics may soon represent a $200 billion market despite a few inherent limitations. The processes for manufacturing therapeutic proteins are not very efficient…
Can Gene Therapy Cure Sickle Cell Disease?
November 8, 2021
Despite being one of the world’s most common inherited blood disorders, sickle cell disease has few treatment options, even with the approval of three…
The Flu Shot and COVID: Will the Delta Variant Play a Role?
November 3, 2021
Cold and flu season is nearly here, with flu activity typically peaking between the months of December and February. But according to a recent…
New Hope for Ultra-Rare Childhood Disease
November 1, 2021
The recent release of findings from a small Phase 1 clinical trial not only gives hope to families affected by an ultra-rare childhood disease,…
CRISPR and the Continuing Quest for CAR-T Safety and Durability
October 27, 2021
CAR-T is an immunotherapy that is currently used to treat blood cancers and is in clinical trials to treat other cancers as well. This…
mRNA: Great Expectations vs. Limited Applications
October 18, 2021
While research on potential therapeutic applications of mRNA has been underway for more than a decade, the success of the Pfizer and Moderna COVID-19…
Will You Need a COVID-19 Vaccine Booster Shot?
October 13, 2021
On September 22, 2021, the U.S. Food and Drug Administration (FDA) approved a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for specific communities….
When COVID-19 Vaccine Supply Doesn’t Meet the Need, Innovations Emerge
October 11, 2021
It is hard to believe that within one year of the declaration of the pandemic, as many as eleven COVID-19 vaccines received emergency authorized…
COVID-19 Symptoms in the Vaccinated vs. Unvaccinated
October 6, 2021
Earlier this month, the United States reached a crucial milestone: Per the Centers for Disease Control and Prevention (CDC) website, 55 percent of the…
How SARS-CoV-2 Spreads Infection So Efficiently | Part 3 – Invasion of the Variants
October 4, 2021
In the first two blogs of this three-part series on how SARS-CoV-2 spreads, QPS has covered how the SARS-CoV-2 spike protein can attach to…
Move Over AAV – Anelloviruses May Be Key to NextGen Gene Therapy
September 27, 2021
Biotech start-up Ring Therapeutics, founded by Flagship Pioneering in 2017, hopes to transform gene therapy by using a new class of vector — anelloviruses…
How SARS-CoV-2 Spreads Infection so Efficiently | Part 2 – Hijacking Host Cells
September 20, 2021
Like most viruses, SARS-CoV-2 infects its hosts by entering and “hijacking” the operations of a host cell. A significant amount of the research on…
Customized Therapies Offer Hope for Patients with Ultra-Rare Genetic Diseases
March 18, 2024
Leveraging rapid developments in gene therapy, researchers are designing new ways to target ultra-rare genetic diseases with treatments tailored to a patient’s specific genetic…
Navigating Changes to EU Clinical Trial Management: What You Need to Know
March 13, 2024
The face of clinical trials in the European Union (EU) is changing. By January 31, 2025, all ongoing clinical trials must move to the…
Psychoactive Drug Ibogaine Has Transformative Effects for Veterans with Traumatic Brain Injury
March 11, 2024
Traumatic brain injuries (TBIs), commonly experienced by military personnel, often incur deep damage and invisible scars. Such injuries are significant contributors to post-traumatic stress…
The Link Between Obesity Drugs and Brain Health
March 6, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are arguably the hottest topic in medical innovation. The drugs semaglutide and tirzepatide, known under brand names like Ozempic,…
Advances in Treating Autoimmune Diseases Focus on Restoring Immune Tolerance
March 4, 2024
For decades, the battle against autoimmune diseases like type 1 diabetes, lupus, and multiple sclerosis has been an uphill struggle. Conventional treatments most often…
Research Challenges Conventional Wisdom on Obesity and Mortality
February 26, 2024
Research using data from a large U.S. health survey has disrupted conventional thinking about body mass index (BMI) and its role in predicting all-cause…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
GRONINGEN, Netherlands–(BUSINESS WIRE)–QPS Holdings, LLC (QPS) today announced a significant renewal of its elemental bioanalysis infrastructure through the acquisition of two PerkinElmer NexION® 2200…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…